Stellate ganglion blocks for idiopathic sensorineural hearing loss
- PMID: 1244832
- DOI: 10.1001/archotol.1976.00780060051003
Stellate ganglion blocks for idiopathic sensorineural hearing loss
Abstract
Fifty-six patients, treated with a series of anesthetizing blocks of the stellate ganglion for idiopathic sudden sensorineural loss, were compared with 20 patients of similar diagnosis who were treated by other means as to amount of pure-tone gain, speech discrimination improvement, nature of symptoms, and delay in start of surgery. Seventy percent of the stellate-ganglion-block-treated patients achieved substantial hearing improvement. Only 15% to 20% of the non-stellate-ganglion-block-treated patients achieved substantial hearing improvement in discrimination or pure-tone levels. The delay time from onset of symptoms to start of stellate block therapy appears to be important. The type of tinnitus, presence or absence of vertigo, and fullness in the ear may be useful prognostic signs.
Similar articles
-
Effect of stellate ganglion injections guided by different approaches on hearing threshold in patients with sudden deafness.Am J Otolaryngol. 2022 May-Jun;43(3):103201. doi: 10.1016/j.amjoto.2021.103201. Epub 2021 Sep 10. Am J Otolaryngol. 2022. PMID: 35490585 Clinical Trial.
-
Treatment of sudden sensorineural hearing loss with a continuous epidural block.Eur Arch Otorhinolaryngol. 1999;256 Suppl 1:S18-21. doi: 10.1007/pl00014146. Eur Arch Otorhinolaryngol. 1999. PMID: 10337521 Clinical Trial.
-
Hyperbaric oxygen and stellate ganglion blocks for idiopathic sudden hearing loss.Acta Otolaryngol. 1979;88(5-6):335-42. doi: 10.3109/00016487909137177. Acta Otolaryngol. 1979. PMID: 532608
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
-
[The stellate ganglion blockade].Anaesthesist. 1993 Feb;42(2):119-28. Anaesthesist. 1993. PMID: 8470786 Review. German.
Cited by
-
Comparative Analysis of the Combined Therapeutic Effects of Lipoprostaglandin E1 on Sudden Idiopathic Sensorineural Hearing Loss.J Audiol Otol. 2017 Apr;21(1):33-38. doi: 10.7874/jao.2017.21.1.33. Epub 2017 Mar 30. J Audiol Otol. 2017. PMID: 28417106 Free PMC article.
-
The nystagmus and the therapeutic effects on early-diagnosed cases of sudden deafness.Arch Otorhinolaryngol. 1977 Jul 29;217(2):229-36. doi: 10.1007/BF00665542. Arch Otorhinolaryngol. 1977. PMID: 578735
-
Calcium antagonists in the treatment of sudden deafness.Arch Otorhinolaryngol. 1986;243(3):170-3. doi: 10.1007/BF00470614. Arch Otorhinolaryngol. 1986. PMID: 3753293 Clinical Trial.
-
Combination therapy with systemic steroids, an antiviral agent, anticoagulants, and stellate ganglion block for treatment of sudden sensorineural hearing loss.Korean J Audiol. 2012 Sep;16(2):71-4. doi: 10.7874/kja.2012.16.2.71. Epub 2012 Sep 20. Korean J Audiol. 2012. PMID: 24653874 Free PMC article.
-
Management of acute idiopathic sensorineural hearing loss: a survey of UK ENT consultants.Acta Otorhinolaryngol Ital. 2011 Apr;31(2):85-9. Acta Otorhinolaryngol Ital. 2011. PMID: 22058587 Free PMC article.